Cue Health Management
Management criteria checks 1/4
Cue Health's CEO is Clint Sever, appointed in Mar 2024, has a tenure of less than a year. total yearly compensation is $1.35M, comprised of 40.8% salary and 59.2% bonuses, including company stock and options. directly owns 2.07% of the company’s shares, worth $304.99K. The average tenure of the management team and the board of directors is 2 years and 2.7 years respectively.
Key information
Clint Sever
Chief executive officer
US$1.4m
Total compensation
CEO salary percentage | 40.8% |
CEO tenure | less than a year |
CEO ownership | 2.1% |
Management average tenure | 2yrs |
Board average tenure | 2.7yrs |
Recent management updates
Recent updates
Take Care Before Jumping Onto Cue Health Inc. (NASDAQ:HLTH) Even Though It's 26% Cheaper
May 10Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%
Mar 22Cue Health Inc.'s (NASDAQ:HLTH) Price Is Right But Growth Is Lacking After Shares Rocket 31%
Jan 28We're A Little Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Rate
Jan 06Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 28%
Nov 10These Analysts Think Cue Health Inc.'s (NASDAQ:HLTH) Sales Are Under Threat
Aug 14Can Cue Health (NASDAQ:HLTH) Afford To Invest In Growth?
Jul 12Revenue Downgrade: Here's What Analysts Forecast For Cue Health Inc. (NASDAQ:HLTH)
May 15Cue Health Inc. (NASDAQ:HLTH) Analysts Just Slashed This Year's Revenue Estimates By 56%
Mar 21We Think Cue Health (NASDAQ:HLTH) Needs To Drive Business Growth Carefully
Mar 12Cue Health Inc.'s (NASDAQ:HLTH) Intrinsic Value Is Potentially 44% Above Its Share Price
Feb 13Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%
Nov 18Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation
Oct 30Cue Health applies for FDA emergency use nod for its flu & COVID-19 molecular test
Oct 04Cue Health appoints chief medical oficer
Sep 08CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$1m | US$552k | -US$373m |
Sep 30 2023 | n/a | n/a | -US$257m |
Jun 30 2023 | n/a | n/a | -US$276m |
Mar 31 2023 | n/a | n/a | -US$291m |
Dec 31 2022 | US$3m | US$548k | -US$194m |
Sep 30 2022 | n/a | n/a | -US$138m |
Jun 30 2022 | n/a | n/a | -US$67m |
Mar 31 2022 | n/a | n/a | US$34m |
Dec 31 2021 | US$49m | US$418k | US$33m |
Sep 30 2021 | n/a | n/a | -US$11m |
Jun 30 2021 | n/a | n/a | -US$24m |
Mar 31 2021 | n/a | n/a | -US$37m |
Dec 31 2020 | US$4m | US$243k | -US$47m |
Compensation vs Market: Clint's total compensation ($USD1.35M) is above average for companies of similar size in the US market ($USD658.32K).
Compensation vs Earnings: Clint's compensation has been consistent with company performance over the past year.
CEO
Clint Sever (38 yo)
less than a year
Tenure
US$1,352,114
Compensation
Mr. Clint Sever has been Chief Executive Officer at Cue Health Inc. since March 20, 2024. He is Co-Founder of Cue Health and served as its Chief Product Officer since its inception in January 2010. Mr. Sev...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder & CEO | less than a year | US$1.35m | 2.07% $ 305.0k | |
Chief Accounting Officer | 2.1yrs | no data | 0.050% $ 7.4k | |
Chief Marketing Officer | 2.4yrs | no data | no data | |
Chief Human Resources Officer | 1.8yrs | no data | no data | |
Chief Business Officer & Director | 2.9yrs | no data | 1.28% $ 188.8k | |
Chief Medical Officer | 1.7yrs | no data | no data |
2.0yrs
Average Tenure
44.5yo
Average Age
Experienced Management: HLTH's management team is not considered experienced ( 2 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Business Officer & Director | 6yrs | no data | 1.28% $ 188.8k | |
Lead Independent Director | 2.7yrs | US$106.55k | 0.038% $ 5.6k | |
Independent Director | 2.7yrs | US$92.55k | 0.038% $ 5.6k | |
Independent Director | 1.6yrs | US$95.55k | 0.019% $ 2.8k | |
Independent Director | 2.7yrs | US$103.55k | 0.038% $ 5.6k | |
Independent Director | 1.8yrs | US$107.55k | 0.045% $ 6.6k |
2.7yrs
Average Tenure
57yo
Average Age
Experienced Board: HLTH's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/05/28 23:39 |
End of Day Share Price | 2024/05/28 00:00 |
Earnings | 2023/12/31 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cue Health Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ishan Majumdar | Baptista Research |
Mark Massaro | BTIG |
Matthew Sykes | Goldman Sachs |